Skip to content

Lymph Node Mapping Via Flourescent Dye in Colon Cancer

Lymph Node Mapping Via the Flourescent Dye ICG in Colon Cancer Through Preoperative Application

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04959604
Enrollment
30
Registered
2021-07-13
Start date
2021-05-31
Completion date
2026-12-30
Last updated
2023-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Carcinoma, Lymph Node Metastases

Keywords

indocyanine green, lymphatic mapping, fluorescence

Brief summary

The aim of the study is to evaluate whether lymph nodes draining the region of the carcinoma are located only inside the lines of standard resection or in some percentages are located outside as well. The visualized nodes draining the region of the carcinoma will be correlated to location, fluorescent yes/no and nodal positive/negative. The draining lymph nodes will be visualized using the fluorescent dye indocyanine green. The aim of the study is to evaluate whether lymph nodes draining the region of the carcinoma are located only inside the lines of standard resection or in some percentages are located outside as well. The visualized nodes draining the region of the carcinoma will be correlated to location, fluorescent yes/no and nodal positive/negative. The draining lymph nodes will be visualized using the fluorescent dye indocyanine green.

Detailed description

Participants with a diagnosed (andeno)carcinoma of the ascending, transverse, descending and sigmoid colon will be included. Preoperatively the participants will receive an indocyanine green(ICG) injection at four points around the tumour endoscopically. The ICG marking will take place one to five days prior to surgery. In the draining lymph nodes of the specific region the ICG will accumulate and thus visible via fluorescence-camera during the surgery. Intraoperatively, the precise locations of all fluorescent nodes will be documented photographically. A standard resection and lymph node dissection will be conducted, potential fluorescent nodes outside the standard resection lines will additionally be resected. The fresh specimen will then be measured, the fluorescent nodes marked and after the pathologic examination the nodes will be correlated to location, fluorescent yes/no and nodal positive/negative. The aim ist not the visualization of the Sentinel node or the directly draining lymphatic vessel but all the nodes draining the peritumorous region at the point of surgery.

Interventions

PROCEDUREICG-marking endoscopically

Preoperatively the participants will receive an endoscopic marking at four points around the tumour with the fluorescent dye indocyanine green.

Sponsors

Universitätsklinikum Hamburg-Eppendorf
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Intervention group. Participants will receive a state of the art surgical procedure with additional lymph node mapping

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* histologically diagnosed carcinoma of the ascending, transverse, descending or sigmoid colon.

Exclusion criteria

* not wanting to participate * other carcinoma then adenocarcinoma * endoscopic marking not possible

Design outcomes

Primary

MeasureTime frameDescription
Intraoperative ICG-positive lymph nodes in vivo after endoscopic marking of the tumourintraoperative assessmentCounting ICG-positive sites intraoperatively
Video-analysis of ICG-positive lymph nodes in vivo after endoscopic marking of the tumourvideo-analysis within one week after surgeryCounting ICG-positive sites video-analysis
Number of ICG-positive lymph nodes after endoscopic marking of the tumourwithin one week after surgeryPicking ICG-positive lymph nodes ex vivo in unfixed specimen, sending ICG positive nodes separately to pathological examination
Correlation of nodal-positive lymph nodes inside/outside the standard resection areawithin one week after surgeryICG-positive sites outside standard resection area will be cherry picked, sent to pathological examination separatively.

Countries

Germany

Contacts

Primary ContactKatharina L Lucas, MD
katharina.lucas@uni-wh.de+4915779600815
Backup ContactJulia-Kristin Grass, Dr.
j.grass@uke.de+4915222815011

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026